Skip to main content
Clinical Trials/NCT02395289
NCT02395289
Completed
N/A

The Efficacy of Cognitive-Based Compassion Training for Enhancing Immune Restoration and Psychological Adaptation in Individuals Living With HIV Disease

Emory University1 site in 1 country54 target enrollmentMarch 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Human Immunodeficiency Virus
Sponsor
Emory University
Enrollment
54
Locations
1
Primary Endpoint
Change in plasma concentration of circulating inflammatory biomarker interleukin-6 (IL-6)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of the study is to examine the effects of cognitive-based compassion training (CBCT), a meditative practice based on Buddhist teachings, on long term emotional well-being and immune system improvement with people living with Human Immunodeficiency Virus (PLHIV).

Detailed Description

The proposed study will investigate the efficacy of cognitive-based compassion training (CBCT), a contemplative technique based on the Tibetan Buddhist tradition of compassion meditation, for enhancing immune restoration and psychological resilience in people living with HIV-1 (PLHIV). Psychosocial stress has been associated with increased circulating concentrations of key inflammatory biomarkers. The patients with HIV must cope with the physical impact of HIV disease itself, the often complex treatment regimens and side effects of combination antiretroviral therapy (ART), illness-associated psychological and existential dilemmas, changes in social roles and lifestyle patterns relative to illness progression, social stigma, and financial and material resource concerns. This study aims to determine if engagement with CBCT is associated with reduced circulating concentrations of stress-related inflammatory biomarkers, improves HIV-related clinical outcomes and decreases stress in PLHIV.

Registry
clinicaltrials.gov
Start Date
March 2016
End Date
December 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mehul Tejani

Assistant Professor

Emory University

Eligibility Criteria

Inclusion Criteria

  • Subjects living with HIV-1 infection who have been on continuous ART for a minimum of 12 months and:
  • are followed longitudinally for their HIV healthcare at the Infectious Disease Program
  • meet criteria for immunological non-responsiveness as defined by adherence to ART and cluster of differentiation 4 (CD4) count \<350 cells/μL despite complete virologic suppression (\> 2 plasma HIV viral load (pVL) below the limit of detection including the most recent pVL prior to enrollment).
  • Ability to give informed consent.
  • Score at least 1 standard deviation above socioeconomic status (SES)-matched general population norms on Perceived Stress Scale (PSS)

Exclusion Criteria

  • History of psychosis
  • HIV-related neurocognitive decline
  • Substance abuse within the last year
  • Documented history of cirrhosis or a total bilirubin ≥ 2.0 mg/dL
  • Known or possible pregnancy or attempting to become pregnant
  • BMI below 17 or above 30
  • Bipolar disorder
  • Bleeding disorders such as thrombocytopenia or significant gastrointestinal bleeding within the past year
  • Continuous ART for \< 12 months

Outcomes

Primary Outcomes

Change in plasma concentration of circulating inflammatory biomarker interleukin-6 (IL-6)

Time Frame: screening, 8 weeks

The plasma concentrations of IL-6 will be assessed using commercial enzyme-linked immunoassay (ELISA) kits.

Change in plasma concentration of circulating inflammatory biomarker soluble cluster of differentiation 14 (sCD14)

Time Frame: screening, 8 weeks

The plasma concentrations of sCD14 will be assessed using commercial enzyme-linked immunoassay (ELISA) kits.

Secondary Outcomes

  • Change in scores on the Illness Cognition Questionnaire (ICQ)(Screening, 8 weeks)
  • Change in scores on the Berger HIV Stigma Scale(Screening, 8 weeks)
  • Change in scores on the World Assumptions Scale (WAS)(Screening, 8 weeks)
  • Change in scores on the Rosenberg self-esteem scale(Screening, 8 weeks)
  • Change in scores on the Perceived Stress Scale (PSS)(Screening, 8 weeks)
  • Acceptance of Cognitive-Based Compassion Training (CBCT), measured by participant satisfaction(8 weeks)
  • Change in serum levels of C-reactive protein (CRP)(Screening, 8 weeks)
  • Change in scores on the General Well-Being (GWB) Schedule Scale(Screening, 8 weeks)
  • Change in scores on the Life Regard Index - Revised (LRI-R).(Screening, 8 weeks)

Study Sites (1)

Loading locations...

Similar Trials